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FIGURE 1. Digital subtraction angiogram showing filling of a branch of the right bronchial artery from the thoracic aorta (A) and filling of the hemangiom-
atous portion through the right bronchial artery (B).
Brief CommunicationsEarly calcification of a stentless pericardial bioprosthesis
in the elderly
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Gaetano Thiene, MD,b and Uberto Bortolotti, MD,a Pisa and Padova, ItalyThe Sorin Freedom pericardial valve (SFP, Sorin Biomedi-
caCardio, Saluggia, Italy), a stentless bioprosthesis made
of glutaraldehyde-tanned bovine pericardium, was intro-
duced clinically in 1991.1 In 2000, detoxification treatment
with homocysteic acid was added to eliminate glutaralde-
hyde toxicity and mitigate tissue calcification. The SFP
has shown excellent overall results at medium term with
no cases of structural failure.2 We report the first case of
early SFP calcification in an elderly recipient.
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An 84-year-old woman underwent aortic valve replace-
ment in 2000 with a 25-mm SFP, implanted with 3 continu-
ous sutures of 4-0 polypropylene to secure the inflow and
outflow rims; intraoperative echocardiography showed
a competent valve. Approximately 6 years later she was hos-
pitalized for acute pulmonary edema. A harsh precordial
systolic murmur was audible, and electrocardiography
showed sinus rhythm and left ventricular hypertrophy.
Echocardiography revealed calcified valve cusps with
a peak transvalvular gradient of 100 mm Hg and a valve
area of 0.8 cm2. No evident risk factors for bioprosthetic cal-
cification were detected; renal function was normal (serum
creatinine 0.78 mg/dL) with no hyperlipidemia, and hyper-
parathyroidism was excluded by normal calcium and phos-
phate values. At reoperation, the prosthesis appeared
incorporated into the aortic wall; all cusps were calcified
(Figure 1), and calcification extended to the outflow of the
prosthesis preventing its complete removal. The 3 cusps
were separately excised leaving a rigid diminutive aorticrdiovascular Surgery c Volume 137, Number 5 1273
Brief CommunicationsFIGURE 1. Gross (A), x-ray (B), and histologic (C) views of the explanted cusps with massive calcification (von Kossa stain, magnification 36).annulus; this was enlarged with a patch of bovine pericar-
dium allowing the insertion of a 21-mm Perimount Magna
pericardial bioprosthesis (Edwards Lifesciences, Irvine, Ca-
lif). The patient recovered uneventfully.
DISCUSSION
Intrinsic calcification is the leading cause of bioprosthetic
failure and reoperation. In the elderly, mineralization of bio-
prostheses occurs slowly, thus justifying their extended use
in this patient subset because the prosthesis will most likely
outlive the recipient.3 Stentless bioprostheses have been re-
ported to be hemodynamically superior to stented biopros-
theses and with potentially longer durability, thus gaining
popularity in recent years as a valve substitute in the elderly.41274 The Journal of Thoracic and Cardiovascular SuThe SPF is a stentless bioprosthesis made entirely of bo-
vine pericardium with excellent hemodynamic performance
and durability at medium term, with no reports of valve min-
eralization. The present case shows 2 interesting features.
First, it describes early bioprosthetic calcification in an
elderly patient without evident risk factors after aortic valve
replacement with a first-generation SPF, a prosthesis without
any antimineralization treatment. Bioprosthetic calcification
in the elderly is considered exceptional.5 Because such
a complication has not been reported even in large series
of patients receiving an SPF,2,4 our case may be an occa-
sional finding. Second, it underlines the potential complex-
ity of replacing a stentless valve, which might require
a more technically demanding procedure. In our case, thergery c May 2009
Brief Communicationspresence of a small, rigid aortic annulus mandated an annu-
lar enlargement procedure to insert a prosthesis of adequate
size, and calcification of the prosthesis outflow discouraged
the use of a second stentless valve.
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Surgical treatment of active infective valvular endocarditis is
associated with substantial morbidity and mortality, particu-
larly when the infection spreads below the primary infected
valve. We report the case of a patient in whom acute mitral
regurgitation (MR) developed secondary to the rupture of
both papillary muscles (PMs) after aortic valve replacement
(AVR) for infective endocarditis.
CLINICAL SUMMARY
A previously healthy 23-year-old morbidly obese man was
transferred to our hospital with a 5-day history of left-sided
chest pain, dyspnea, cough, and fever. On arrival, his blood
pressure was 120/48 mm Hg, with a regular pulse rate of
148 beats/min, a temperature of 38.6C, a respiratory rate of
26 breaths/min, and an oxygen saturation of 86% on room
air. The only remarkable physical findings were a grade III/
VI long, diastolic, blowing murmur at the right second inter-
space and a progressively decreasing level of consciousness,
withnofocalneurologic signs.After intubation, a transesopha-
geal echocardiogram revealed the presence of a 1 3 3-cm
vegetation involving the right and left aortic leaflets and
associated with severe aortic insufficiency with an ejection
fraction of 30%. There was no evidence of abscess, and
the anterior mitral leaflet was intact with minimal MR.
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The patient was taken to the operating room for an emer-
gency AVR. Under cardiopulmonary bypass, an aortotomy
was performed and the aortic valve (AV) was excised. A 2-
cm aortic abscess involving the ventricular septum was
identified. After thorough debridement of all the infected tis-
sue, reconstruction of the aortic annulus was achieved using
bovine pericardium followed by insertion of a number 21 St
Jude mechanical valve (St Jude Medical Inc, St Paul, Minn).
Postoperatively, the patient’s condition gradually im-
proved. However, on postoperative day 4, the patient’s fever
spiked to, his white count increased to 37.5, his systolic pres-
sure decreased to 70 mm Hg, and his wedge pressure in-
creased to 28 mm Hg. Shortly thereafter, cardiac arrest
occurred and the patient died after attempted resuscitation
for more than 30 minutes.
Examination of the heart at autopsy revealed a competent
AV with no vegetation or thrombus. However, both the an-
terior and posterior PMs were ruptured and the posteroseptal
myocardium contained a 2.5 3 1.5-cm abscess (Figure 1).
Histologic examination showed myocardial necrosis and
marked acute inflammation of both papillary heads, consis-
tent with septic embolization of the small coronary branches
supplying these muscles. Gram-positive cocci, consistent
with Group B streptococcus found in blood cultures, were
identified in the necrotic tissue. Additional foci of septic em-
bolization were seen in the kidneys and spleen.
DISCUSSION
Aortic root infection occurs in one third of all patients
with native valve endocarditis and is associated with sub-
stantial morbidity and mortality.1 The major determinants
for the successful surgical management of these cases are
the complete exclusion and thorough debridement of the
infected cavities.2 MR in the setting of AV endocarditis is
ardiovascular Surgery c Volume 137, Number 5 1275
